2.5900 0.00 (0.00%)
After hours: 4:17PM EST
|Bid||2.5900 x 1000|
|Ask||2.7100 x 800|
|Day's Range||2.5450 - 2.6541|
|52 Week Range||2.4000 - 4.4600|
|Beta (5Y Monthly)||1.17|
|PE Ratio (TTM)||172.67|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Anyone researching Enzo Biochem, Inc. (NYSE:ENZ) might want to consider the historical volatility of the share price...
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips. That outperformance comes with a price, however, as there are occasional periods of higher volatility. The last 12 months is one of those periods, as the Russell 2000 […]
For many, the main point of investing is to generate higher returns than the overall market. But even the best stock...
If you're interested in Enzo Biochem, Inc. (NYSE:ENZ), then you might want to consider its beta (a measure of share...
After nearly 38 years, small cap, biotech expert Bill Mathews is retiring as editor of The Cheap Investor; we wish Bill and his wife Karen the very best for their coming years. Meanwhile, we leave our readers with some of Bill's parting comments on some of his favorite biotech ideas.
A look at the shareholders of Enzo Biochem, Inc. (NYSE:ENZ) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the small...
On a per-share basis, the New York-based company said it had a loss of 18 cents. The life sciences and biotechnology company posted revenue of $19.3 million in the period. In the final minutes of trading ...
In 1976 Elazar Rabbani was appointed CEO of Enzo Biochem, Inc. (NYSE:ENZ). First, this article will compare CEO compensation with compensation at similar sized companies. Next, we'll consider growth thatRead More...